The use of Pimavanserin in the treatment of Parkinson’s Disease: a consideration of its effects on sleep
Defining Extreme Phenotypes of OSA across International Sleep Centers
Sleep disturbances as an adverse effect of propranolol use in children with infantile hemangioma
Sublingual and oral zolpidem for insomnia disorder: a 3-month randomized trial
Exercise for “Sleep Rehabilitation” in Parkinson’s Disease